ペプチドリーム株式会社は、 非標準のペプチド治療薬の発見と開発を目的とした東京大学発のバイオベンチャー企業です。 PeptiDream Inc is involved in the discovery and development of nonstandard peptide therapeutics.
Employees: 51-200
Founded date: 2006
Investors 2
| Date | Name | Website |
| 10.07.2026 | The Univer... | ut-ec.co.j... |
| - | J-Startup | j-startup.... |
Mentions in press and media 8
| Date | Title | Description |
| 02.11.2022 | В Японии начинает формироваться культура сложнотехнологических стартапов | Давно пора: молодые компании, связанные с химией и технологической индустрией, завоевывают внимание японского правительства и бизнеса В тех частях Японии, которые не подключены к трубопроводной сети, пропан поставляется в баллонах весом бол... |
| 11.11.2021 | Non-consolidated Financial Results for the Nine Months Ended September 30, 2021[Japanese GAAP] | Non-consolidated Financial Results for the Nine Months Ended September 30, 2021 [Japanese GAAP] November 11, 2021 Company name: PeptiDream Inc. Tokyo Stock Exchange Stock code: 4587 URL https://www.peptidream.com/ Representative: Patrick C.... |
| 20.04.2021 | PEPTIDREAM INC. PeptiDream : Corporate Governance Report 20/04/2021 | Corporate Governance Report Last Update: April 20, 2021 PeptiDream Inc. Patrick C. Reid Representative Director, President & CEO Contact: IR & Public Affairs Department Securities Code: 4587 https://www.peptidream.com/ The corporate... |
| 05.04.2021 | PEPTIDREAM INC. PeptiDream : Announces Achievement of Development Milestone in Discovery Alliance with Bayer | News Release April 5, 2021 PeptiDream Inc. https://www.peptidream.com(Ticker Code: 4587 TSE First Section) PeptiDream Announces Achievement of Development Milestone in Discovery Alliance with Bayer KANAGAWA, JAPAN - April 5th, 2021 - PeptiD... |
| 02.04.2021 | PEPTIDREAM INC. PeptiDream : Corporate Governance Report 02/04/2021 | Corporate Governance Report Last Update: April 2, 2021 PeptiDream Inc. Patrick C. Reid Representative Director, President & CEO Contact: IR & Public Affairs Department Securities Code: 4587 https://www.peptidream.com/ The corporate ... |
| 14.10.2020 | RayzeBio debuts with $45M to target tumors with radiopharmaceuticals | Radiation, one of the most widely used and effective cancer therapies, is traditionally administered through external beams targeted at the site of a tumor—which Ken Song, M.D., CEO of the newly unveiled company RayzeBio, calls “an incredib... |
| 07.04.2017 | PeptiDream and J&J ink billion-dollar drug discovery deal | At the heart of the deal is PeptiDream’s Peptide Discovery Platform System (PDPS), a next-generation tool for finding and optimizing macrocyclics and constrained peptides. It’s a burgeoning scientific approach, which aims to overcome the li... |
| - | PeptiDream and J&J ink billion-dollar drug discovery deal | PeptiDream has once again turned small molecules into big business, signing a new discovery agreement with Johnson & Johnson’s Janssen Pharmaceutical Companies that could be worth up to $1.15 billion. The deal includes an upfront paymen... |